Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17


Estimation of DNA contamination and its sources in genotyped samples.

Zajac GJM, Fritsche LG, Weinstock JS, Dagenais SL, Lyons RH, Brummett CM, Abecasis GR.

Genet Epidemiol. 2019 Aug 26. doi: 10.1002/gepi.22257. [Epub ahead of print]


Microcephaly, intellectual impairment, bilateral vesicoureteral reflux, distichiasis, and glomuvenous malformations associated with a 16q24.3 contiguous gene deletion and a Glomulin mutation.

Butler MG, Dagenais SL, Garcia-Perez JL, Brouillard P, Vikkula M, Strouse P, Innis JW, Glover TW.

Am J Med Genet A. 2012 Apr;158A(4):839-49. doi: 10.1002/ajmg.a.35229. Epub 2012 Mar 9.


A novel VEGFR3 mutation causes Milroy disease.

Butler MG, Dagenais SL, Rockson SG, Glover TW.

Am J Med Genet A. 2007 Jun 1;143A(11):1212-7.


Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome.

Dagenais SL, Hartsough RL, Erickson RP, Witte MH, Butler MG, Glover TW.

Gene Expr Patterns. 2004 Oct;4(6):611-9.


Mutation of the FOXC2 gene in familial distichiasis.

Brooks BP, Dagenais SL, Nelson CC, Glynn MW, Caulder MS, Downs CA, Glover TW.

J AAPOS. 2003 Oct;7(5):354-7.


Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.

Miller CT, Aggarwal S, Lin TK, Dagenais SL, Contreras JI, Orringer MB, Glover TW, Beer DG, Lin L.

Cancer Res. 2003 Jul 15;63(14):4136-43.


FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome.

Kriederman BM, Myloyde TL, Witte MH, Dagenais SL, Witte CL, Rennels M, Bernas MJ, Lynch MT, Erickson RP, Caulder MS, Miura N, Jackson D, Brooks BP, Glover TW.

Hum Mol Genet. 2003 May 15;12(10):1179-85.


The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.

Lin L, Miller CT, Contreras JI, Prescott MS, Dagenais SL, Wu R, Yee J, Orringer MB, Misek DE, Hanash SM, Glover TW, Beer DG.

Cancer Res. 2002 Sep 15;62(18):5273-9.


Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations.

Erickson RP, Dagenais SL, Caulder MS, Downs CA, Herman G, Jones MC, Kerstjens-Frederikse WS, Lidral AC, McDonald M, Nelson CC, Witte M, Glover TW.

J Med Genet. 2001 Nov;38(11):761-6.


A novel frameshift mutation in exon 23 of ATP7A (MNK) results in occipital horn syndrome and not in Menkes disease.

Dagenais SL, Adam AN, Innis JW, Glover TW.

Am J Hum Genet. 2001 Aug;69(2):420-7. Epub 2001 Jun 26.


Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma.

Fang JM, Arlt MF, Burgess AC, Dagenais SL, Beer DG, Glover TW.

Genes Chromosomes Cancer. 2001 Mar;30(3):292-8.


Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome.

Fang J, Dagenais SL, Erickson RP, Arlt MF, Glynn MW, Gorski JL, Seaver LH, Glover TW.

Am J Hum Genet. 2000 Dec;67(6):1382-8. Epub 2000 Nov 8.


The canine copper toxicosis locus is not syntenic with ATP7B or ATX1 and maps to a region showing homology to human 2p21.

Dagenais SL, Guevara-Fujita M, Loechel R, Burgess AC, Miller DE, Yuzbasiyan-Gurkan V, Brewer GJ, Glover TW.

Mamm Genome. 1999 Jul;10(7):753-6. No abstract available.


The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region.

Glover TW, Hoge AW, Miller DE, Ascara-Wilke JE, Adam AN, Dagenais SL, Wilke CM, Dierick HA, Beer DG.

Cancer Res. 1998 Aug 1;58(15):3409-14.


A physical map of the mouse H2 Bat5/Db interval.

Dagenais SL, Nakamura I.

Mamm Genome. 1997 Jan;8(1):39-41. No abstract available.


Supplemental Content

Loading ...
Support Center